The spatiotemporal analysis of SARS-CoV-2 transmission in China since the termination of the dynamic zero-COVID policy

Abstract

Keywords:
• SARS-CoV-2
• , Epidemiology
• , Dynamic zero-COVID policy
• , Population immunity
• , Recombination

Electronic Supplementary Material

10.1016j.virs.2024.09.003-ESM4.xlsx
10.1016j.virs.2024.09.003-ESM1.docx
10.1016j.virs.2024.09.003-ESM6.xlsx
10.1016j.virs.2024.09.003-ESM2.xlsx
10.1016j.virs.2024.09.003-ESM9.xlsx
10.1016j.virs.2024.09.003-ESM8.xlsx
10.1016j.virs.2024.09.003-ESM7.xlsx
10.1016j.virs.2024.09.003-ESM5.xlsx
10.1016j.virs.2024.09.003-ESM3.xlsx

References

1. Aksamentov, I., Roemer, C., Hodcroft, E. B., Neher, R. A., 2021. Nextclade: clade assignment, mutation calling and quality control for viral genomes. J. Open Source Softw. 6, 3773.
   

2. Alteri, C., Cento, V., Piralla, A., Costabile, V., Tallarita, M., Colagrossi, L., Renica, S., Giardina, F., Novazzi, F., Gaiarsa, S. et al., 2021. Genomic epidemiology of SARS-CoV-2 reveals multiple lineages and early spread of SARS-CoV-2 infections in Lombardy, Italy. Nat. Commun. 12, 434.
   

3. Andrews, N., Stowe, J., Kirsebom, F., Toffa, S., Rickeard, T., Gallagher, E., Gower, C., Kall, M., Groves, N., O’Connell, A.M. et al., 2022. Covid-19 vaccine effectiveness against the Omicron (B.1.1.529) variant. N. Engl. J. Med. 386, 1532-1546.
   

4. Ba, Z., Li, Y., Ma, J., Qin, Y., Tian, J., Meng, Y., Yi, J., Zhang, Y., Chen, F., 2023. Reflections on the dynamic zero-COVID policy in China. Prev. Med. Rep. 36, 102466.
   

5. Chen, C., Nadeau, S., Yared, M., Voinov, P., Xie, N., Roemer, C., Stadler, T., 2022. CoV-Spectrum: analysis of globally shared SARS-CoV-2 data to identify and characterize new variants. Bioinformatics. 38, 1735-1737.
   

6. Cheng, Y., Ji, C., Han, N., Li, J., Xu, L., Chen, Z., Yang, R., Zhou, H.Y., Wu, A., 2022. covSampler: a subsampling method with balanced genetic diversity for large-scale SARS-CoV-2 genome data sets. Virus Evol. 8, veac071.
   

7. Chinese Center for Disease Control and Prevention (China CDC), 2023. COVID-19 clinical and surveillance data - December 9, 2022 to January 23, 2023, China. https://en.chinacdc.cn/news/latest/202301/W020230126558725888448.pdf (accessed 2 March 2024).
   

8. CNCB-NGDC Members and Partners, 2023. Database resources of the National Genomics Data Center, China National Center for Bioinformation in 2023. Nucleic Acids Res. 51, D18-D28.
   

9. Colson, P., Gautret, P., Delerce, J., Chaudet, H., Pontarotti, P., Forterre, P., Tola, R., Bedotto, M., Delorme, L., Bader, W. et al., 2023. The emergence, spread and vanishing of a French SARS-CoV-2 variant exemplifies the fate of RNA virus epidemics and obeys the Mistigri rule. J. Med. Virol. 95, e28102.
   

10. Eaton, K., 2023. Rebar (REcombination BARcode detector). https://github.com/phac-nml/rebar (accessed 30 November 2023).
    

11. Franceschi, V.B., Ferrareze, P.A.G., Zimerman, R.A., Cybis, G.B., Thompson, C.E., 2021. Mutation hotspots and spatiotemporal distribution of SARS-CoV-2 lineages in Brazil, February 2020-2021. Virus Res. 304, 198532.
    

12. Goldberg, E.E., Lin, Q., Romero-Severson, E.O., Ke, R., 2023. Swift and extensive Omicron outbreak in China after sudden exit from “zero-COVID” policy. Nat. Commun. 14, 3888.
    

13. Hadfield, J., Megill, C., Bell, S.M., Huddleston, J., Potter, B., Callender, C., Sagulenko, P., Bedford, T., Neher, R.A., 2018. Nextstrain: real-time tracking of pathogen evolution. Bioinformatics. 34, 4121-4123.
    

14. Huang, J., Zhao, S., Chong, K.C., Zhou, Y., Lu, W., Fang, F., Cheung, P.P.H., Lai, K.C., Hui, D.S., Mok, C.K.P., 2023. Infection rate in Guangzhou after easing the zero-COVID policy: seroprevalence results to ORF8 antigen. Lancet. Infect. Dis. 23, 403-404.
    

15. Ioannidis, J.P.A., Zonta, F., Levitt, M., 2023. Estimates of COVID-19 deaths in Mainland China after abandoning zero COVID policy. Eur. J. Clin. Invest. 53, e13956.
    

16. Letko, M., Marzi, A., Munster, V., 2020. Functional assessment of cell entry and receptor usage for SARS-CoV-2 and other lineage B betacoronaviruses. Nat. Microbiol. 5, 562-569.
    

17. Leung, K., Lau, E.H.Y., Wong, C.K.H., Leung, G.M., Wu, J.T., 2023. Estimating the transmission dynamics of SARS-CoV-2 Omicron BF.7 in Beijing after adjustment of the zero-COVID policy in November-December 2022. Nat. Med. 29, 579-582.
    

18. Levi, R., Zerhouni, E.G., Altuvia, S., 2024. Predicting the spread of SARS-CoV-2 variants: An artificial intelligence enabled early detection. PNAS Nexus 3, pgad424.
    

19. Li, J., Zhou, Cheng, Y., Ji, C., Weng, S., Han, N., Yang, R., Zhou, H., Wu, A., 2023. Comprehensive detection and dissection of interlineage recombination events in the SARS-CoV-2 pandemic. Preprint in Research Square platform. https://doi.org/10.21203/rs.3.rs-2924668/v2.
    

20. Li, X., Zhang, Y., Zhang, J., Sui, Z., Qu, X., Wang, M., Miao, T., Li, J., 2023. Genomic surveillance of SARS-CoV-2 in Weihai, China, march 2022 to march 2023. Front. Public Health 11, 1273443.
    

21. Liu, L., Liu, H., 2023. Levels of antibodies to SARS-CoV-2 at key time points during the COVID-19 pandemic in China. Front. Public Health 11, 1271917.
    

22. Liu, P., Xu, J., 2023. Genomic surveillance of SARS-CoV-2 in mainland China after ending the zero-COVID policy, December 2022-January 2023. J. Infect. 86, e84-e86.
    

23. Liu, P., Cai, J., Tian, H., Li, J., Lu, L., Xu, M., Zhu, X., Fu, X., Wang, X., Zhong, H. et al., 2024. Characteristics of SARS-CoV-2 Omicron BA. 5 variants in Shanghai after ending the zero-COVID policy in December 2022: a clinical and genomic analysis. Front. Microbiol. 15, 1372078.
    

24. Markov, P. V, Ghafari, M., Beer, M., Lythgoe, K., Simmonds, P., Stilianakis, N.I., Katzourakis, A., 2023. The evolution of SARS-CoV-2. Nat. Rev. Microbiol. 21, 361-379.
    

25. Messacar, K., Baker, R.E., Park, S.W., Nguyen-Tran, H., Cataldi, J.R., Grenfell, B., 2022. Preparing for uncertainty: endemic paediatric viral illnesses after COVID-19 pandemic disruption. Lancet 400, 1663-1665.
    

26. Minh, B.Q., Schmidt, H.A., Chernomor, O., Schrempf, D., Woodhams, M.D., Von Haeseler, A., Lanfear, R., 2020. IQ-TREE 2: new models and efficient methods for phylogenetic inference in the genomic era. Mol. Biol. Evol. 37, 1530-1534.
    

27. Moeti, M., Gao, G.F., Herrman, H., 2022. Global pandemic perspectives: public health, mental health, and lessons for the future. Lancet 400, e3-e7.
    

28. Pan, Y., Wang, L., Feng, Z., Xu, H., Li, F., Shen, Y., Zhang, D., Liu, W.J., Gao, G.F., Wang, Q., 2023. Characterisation of SARS-CoV-2 variants in Beijing during 2022: an epidemiological and phylogenetic analysis. Lancet 401, 664-672.
    

29. Price, M.N., Dehal, P.S., Arkin, A.P., 2010. FastTree 2-approximately maximum-likelihood trees for large alignments. PLoS One 5, e9490.
    

30. Roemer, C., 2020. Pango-designation of CoV-lineages. https://github.com/cov-lineages/pango-designation/blob/master/lineage_notes.txt (accessed 23 April 2024).
    

31. Ryu, S., Chun, J.Y., Lee, S., Yoo, D., Kim, Y., Ali, S.T., Chun, B.C., 2022. Epidemiology and transmission dynamics of infectious diseases and control measures. Viruses 14, 2510.
    

32. Sagulenko, P., Puller, V., Neher, R.A., 2018. TreeTime: maximum-likelihood phylodynamic analysis. Virus Evol. 4, vex042.
    

33. Shang, J., Wan, Y., Luo, C., Ye, G., Geng, Q., Auerbach, A. and Li, F., 2020. Cell entry mechanisms of SARS-CoV-2. Proc. Natl. Acad. Sci. U S A. 117, 11727-11734.
    

34. Shu, Y., McCauley, J., 2017. GISAID: global initiative on sharing all influenza data - from vision to reality. Euro. Surveill. 22, 30494.
    

35. South, A., 2011. rworldmap: a new R package for mapping global data. R. J. 3, 35-43.
    

36. Suk, J.E., Van Cangh, T., Beaute, J., Bartels, C., Tsolova, S., Pharris, A., Ciotti, M., Semenza, J.C., 2014. The interconnected and cross-border nature of risks posed by infectious diseases. Glob. Health Action 7, 25287.
    

37. Tan, W., Zhao, X., Ma, X., Wang, W., Niu, P., Xu, W., Gao, G.F., Wu, G., 2020. A novel coronavirus genome identified in a cluster of pneumonia cases - Wuhan, China 2019-2020. China CDC Wkly. 2, 61-62.
    

38. Tegally, H., San, J.E., Cotten, M., Moir, M., Tegomoh, B., Mboowa, G., Martin, D.P., Baxter, C., Lambisia, A.W., Diallo, A. et al., 2022. The evolving SARS-CoV-2 epidemic in Africa: insights from rapidly expanding genomic surveillance. Science 378, eabq5358.
    

39. Tegally, H., Wilkinson, E., Tsui, J.L., Moir, M., Martin, D., Brito, A.F., Giovanetti, M., Khan, K., Huber, C., Bogoch, I.I. et al., 2023. Dispersal patterns and influence of air travel during the global expansion of SARS-CoV-2 variants of concern. Cell 186, 3277-3290.
    

40. Turakhia, Y., Thornlow, B., Hinrichs, A., McBroome, J., Ayala, N., Ye, C., Smith, K., De Maio, N., Haussler, D., Lanfear, R. et al., 2022. Pandemic-scale phylogenomics reveals the SARS-CoV-2 recombination landscape. Nature 609, 994-997.
    

41. Xia, Y., Zhong, L., Tan, J., Zhang, Z., Lyu, J., Chen, Y., Zhao, A., Huang, L., Long, Z., Liu, N. et al., 2020. How to understand “herd immunity” in COVID-19 pandemic. Front. Cell Dev. Biol. 8, 547314.
    

42. Yu, G., Smith, D.K., Zhu, H., Guan, Y., Lam, T.T., 2017. ggtree: an R package for visualization and annotation of phylogenetic trees with their covariates and other associated data. Methods Ecol. Evol. 8, 28-36.
    

43. Yu, Y., Zhang, J.Y., Ma, H., Han, Y., Cheng, L.X., Tian, X.Y., Wu, J.L., Li, Y., Zhang, Y.W., Chen, D.Y. et al., 2022. Analysis on the infection source of the first local cluster epidemic caused by the VOC/Gamma variant of SARS-CoV-2 in China. Zhonghua Yu Fang Yi Xue Za Zhi 56, 1789-1794. (in Chinese).
    

44. Zhou, L., Wu, Z., Li, Z., Zhang, Y., McGoogan, J.M., Li, Q., Dong, X., Ren, R., Feng, L., Qi, X. et al., 2020. One hundred days of coronavirus disease 2019 prevention and control in China. Clin. Infect. Dis. 72, 332-339.
    

45. Zhou, Y.H., Xu, C., Tao, Y., Gu, M., Zhou, G., Zhou, W., Jin, Y., Xie, J., Xu, B., Zhou, W. et al., 2023. Incidence of SARS-CoV-2 infection in children shortly after ending zero-COVID-19 policy in China on December 7, 2022: a cross-sectional, multicenter, seroepidemiological study. Front. Public Health 11, 1283158.
    

46. Zhu, M., Zeng, Q., Saputro, B.I.L., Chew, S.P., Chew, I., Frendy, H., Tan, J.W., Li, L., 2022. Tracking the molecular evolution and transmission patterns of SARS-CoV-2 lineage B. 1.466. 2 in Indonesia based on genomic surveillance data. Virol. J. 19, 103.
    

Proportional views